CALL 24/7
Canada Lawyers Represent People Injured by Serevent Asthma Inhalers
June 8, 2006 – Researchers conducting a study assessing the safety of Serevent found that the inhaler more than tripled the risk of asthma-related deaths and concluded Serevent and Advair, a similar asthma drug, should not be used.
In addition to the added risk of death, researchers found those using Serevent also were at a greater risk for hospitalization from life-threatening side effects.
Get Your Free Case Evaluation today!
At Greg Monforton & Partners, we only get paid when we obtain a recovery on your behalf.
(866) 320-4770
Free case reviewFDA Committee Recommends Stronger Serevent Warning
July 30, 2005 – The FDA’s Pulmonary-Allergy Drugs Advisory Committee voted to recommend stronger warnings for Serevent. This decision came six months after a clinical study was stopped prematurely after data revealed serious side effects associated with Serevent.
This announcement came approximately one year after the FDA announced it would require GlaxoSmithKline to include more stringent warnings relating to potentially life-threatening side effects of Serevent. A similar warning also was added to GSK’s Advair, another asthma inhaler.
Get Your Free Case Evaluation today!
Free case reviewClinical Study Alerts Researchers to Problems With Serevent
A clinical trial undertaken to assess the safety of Serevent produced alarming results. The study demonstrated that Serevent users were more likely to suffer life-threatening asthma attacks. Fifty patients out of 13,176 given Serevent either died or suffered a life-threatening asthma attack during the course of the clinical trial.
Dr. David Graham, associate science director of the FDA Office of Drug Safety, testified before the U.S. Congress that Serevent poses a significant health risk and urged more stringent action be taken to protect patients. Dr. Graham believed the August 2004 warnings issued by the FDA did not go far enough to protect those taking the drug.
Why Choose Greg Monforton & Partners?
Discover the successful resolutions our firm has achieved for clients across various legal matters in our detailed case results section.
$300+
MILLION RECOVERED
Greg Monforton and Partners has recovered over $300 million for clients who have suffered injuries or losses due to the negligent actions of others.
5
STAR RATED
Our firm has earned a 5-star rating for our commitment to excellence in legal representation and client satisfaction.
40+
YEARS IN BUSINESS
With over nine years of experience in the legal industry, Greg Monforton & Partners brings seasoned expertise and a proven track record of success to every case we handle.
Serevent Lawyers Canada
Greg Monforton and Partners is handling legal claims against GlaxoSmithKline on behalf of Canadians injured by Serevent.
If you or a loved one has been injured by Serevent, we encourage you to contact us. We are representing clients throughout Canada.
For more information about Serevent, please complete our online form.
FREE
No obligation legal consultation
- No upfront cost if we handle your case.
- We are a team of experienced lawyers with a history of delivering results.
- +$1 Billion recovered on behalf of our clients.
Get a Free
Case Evaluation
"*" indicates required fields